<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Men Y</submitter><funding>NICHD NIH HHS</funding><funding>FRAXA Research Foundation</funding><funding>NIMH NIH HHS</funding><funding>NIAAA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation</funding><funding>NIH</funding><pagination>25092-25103</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7547241</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>117(40)</volume><pubmed_abstract>The loss of fragile X mental retardation protein (FMRP) causes fragile X syndrome (FXS), the most common inherited intellectual disability. How the loss of FMRP alters protein expression and astroglial functions remains essentially unknown. Here we showed that selective loss of astroglial FMRP in vivo up-regulates a brain-enriched miRNA, miR-128-3p, in mouse and human FMRP-deficient astroglia, which suppresses developmental expression of astroglial metabotropic glutamate receptor 5 (mGluR5), a major receptor in mediating developmental astroglia to neuron communication. Selective in vivo inhibition of miR-128-3p in FMRP-deficient astroglia sufficiently rescues decreased mGluR5 function, while astroglial overexpression of miR-128-3p strongly and selectively diminishes developmental astroglia</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling.</pubmed_title><pmcid>PMC7547241</pmcid><funding_grant_id>N/A</funding_grant_id><funding_grant_id>R01 MH106490</funding_grant_id><funding_grant_id>R01 MH118827</funding_grant_id><funding_grant_id>R01 MH116582</funding_grant_id><funding_grant_id>R01 MH113780</funding_grant_id><funding_grant_id>R01 NS105200</funding_grant_id><funding_grant_id>MH116582</funding_grant_id><funding_grant_id>NS105339</funding_grant_id><funding_grant_id>MH113780</funding_grant_id><funding_grant_id>U54 HD090256</funding_grant_id><funding_grant_id>MH106490</funding_grant_id><funding_grant_id>R01 AA025128</funding_grant_id><funding_grant_id>R21 NS105339</funding_grant_id><pubmed_authors>Ye L</pubmed_authors><pubmed_authors>Men Y</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Paukert M</pubmed_authors><pubmed_authors>Promes V</pubmed_authors><pubmed_authors>Risgaard RD</pubmed_authors><pubmed_authors>Zhao X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling.</name><description>The loss of fragile X mental retardation protein (FMRP) causes fragile X syndrome (FXS), the most common inherited intellectual disability. How the loss of FMRP alters protein expression and astroglial functions remains essentially unknown. Here we showed that selective loss of astroglial FMRP in vivo up-regulates a brain-enriched miRNA, miR-128-3p, in mouse and human FMRP-deficient astroglia, which suppresses developmental expression of astroglial metabotropic glutamate receptor 5 (mGluR5), a major receptor in mediating developmental astroglia to neuron communication. Selective in vivo inhibition of miR-128-3p in FMRP-deficient astroglia sufficiently rescues decreased mGluR5 function, while astroglial overexpression of miR-128-3p strongly and selectively diminishes developmental astroglia</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-04-04T11:53:51.697Z</modification><creation>2025-04-04T11:53:51.697Z</creation></dates><accession>S-EPMC7547241</accession><cross_references><pubmed>32958647</pubmed><doi>10.1073/pnas.2014080117</doi></cross_references></HashMap>